Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ACOT1 deficiency attenuates high-fat diet–induced fat mass gain by increasing energy expenditure
Timothy D. Heden, … , Chen Chen, Douglas G. Mashek
Timothy D. Heden, … , Chen Chen, Douglas G. Mashek
Published August 10, 2023
Citation Information: JCI Insight. 2023;8(18):e160987. https://doi.org/10.1172/jci.insight.160987.
View: Text | PDF
Research Article Metabolism

ACOT1 deficiency attenuates high-fat diet–induced fat mass gain by increasing energy expenditure

  • Text
  • PDF
Abstract

Acyl-CoA thioesterase 1 (ACOT1) catalyzes the hydrolysis of long-chain acyl-CoAs to free fatty acids and CoA and is typically upregulated in obesity. Whether targeting ACOT1 in the setting of high-fat diet–induced (HFD-induced) obesity would be metabolically beneficial is not known. Here we report that male and female ACOT1KO mice are partially protected from HFD-induced obesity, an effect associated with increased energy expenditure without alterations in physical activity or food intake. In males, ACOT1 deficiency increased mitochondrial uncoupling protein-2 (UCP2) protein abundance while reducing 4-hydroxynonenal, a marker of oxidative stress, in white adipose tissue and liver of HFD-fed mice. Moreover, concurrent knockdown (KD) of UCP2 with ACOT1 in hepatocytes prevented increases in oxygen consumption observed with ACOT1 KD during high lipid loading, suggesting that UCP2-induced uncoupling may increase energy expenditure to attenuate weight gain. Together, these data indicate that targeting ACOT1 may be effective for obesity prevention during caloric excess by increasing energy expenditure.

Authors

Timothy D. Heden, Mallory P. Franklin, Christina Dailey, Mara T. Mashek, Chen Chen, Douglas G. Mashek

×

Figure 2

ACOT1KO modestly increases energy expenditure.

Options: View larger image (or click on image) Download as PowerPoint
ACOT1KO modestly increases energy expenditure.
(A) Oxygen consumption (V...
(A) Oxygen consumption (VO2) time course during the light and dark cycle in 20-week-old control or ACOT1KO mice given the LFD or HFD for 12 weeks (n = 8–9 per group). (B) Average VO2 during the light and dark cycle (n = 8–9 per group). (C) Energy expenditure time course during the light and dark cycle (n = 8–9 per group). (D) Average energy expenditure during the light and dark cycle (n = 8–9 per group). (E) RER time course during the light and dark cycle (n = 8–9 per group). (F) Average RER during the light and dark cycle (n = 8–9 per group). (G) Carbon dioxide production (VCO2) time course during the light and dark cycle (n = 8–9 per group). (H) Activity counts time course during the light and dark cycle (n = 8–9 per group). (I) Relative food intake (n = 6–7 per group). The indirect calorimetry time course figures are 48 hours in length, and during the first 24 hours, the mice were fed and had free access to food, while during the last 24 hours, the mice were fasted without food but had free access to water. The data are presented as mean ± SEM. ANCOVA was used for statistical tests.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts